Inventory Summary of Biogen Inc.

Biogen Inc.'s latest annual inventory in 2023 was 2.52 Billion USD , up 87.99% from previous year.
Biogen Inc.'s latest quarterly inventory in 2024 Q3 was 2.46 Billion USD , down -1.47% from previous quarter.
Biogen Inc. reported annual inventory of 1.34 Billion USD in 2022, down -0.53% from previous year.
Biogen Inc. reported annual inventory of 1.35 Billion USD in 2021, up 26.47% from previous year.
Biogen Inc. reported quarterly inventory of 2.51 Billion USD for 2024 Q1, down -0.42% from previous quarter.
Biogen Inc. reported quarterly inventory of 2.46 Billion USD for 2024 Q3, down -1.47% from previous quarter.

Annual Inventory Chart of Biogen Inc. (2023 - 1989)

Historical Annual Inventory of Biogen Inc. (2023 - 1989)

Year	Inventory	Inventory Growth
2023	2.52 Billion USD	87.99%
2022	1.34 Billion USD	-0.53%
2021	1.35 Billion USD	26.47%
2020	1.06 Billion USD	32.88%
2019	804.2 Million USD	-13.52%
2018	929.9 Million USD	3.01%
2017	902.7 Million USD	-9.87%
2016	1 Billion USD	12.11%
2015	893.4 Million USD	11.12%
2014	804.02 Million USD	22.01%
2013	659 Million USD	47.31%
2012	447.37 Million USD	36.88%
2011	326.84 Million USD	13.07%
2010	289.06 Million USD	-1.66%
2009	293.95 Million USD	11.51%
2008	263.6 Million USD	12.66%
2007	233.98 Million USD	38.37%
2006	169.1 Million USD	-7.5%
2005	182.81 Million USD	-27.17%
2004	251.01 Million USD	-49.43%
2003	496.34 Million USD	420.4%
2002	95.37 Million USD	116.24%
2001	44.1 Million USD	10.14%
2000	40.04 Million USD	-20.8%
1999	50.56 Million USD	90.21%
1998	26.58 Million USD	-28.54%
1997	37.2 Million USD	-22.31%
1996	47.88 Million USD	0.0%
1995	- USD	0.0%
1994	- USD	0.0%
1993	- USD	0.0%
1992	- USD	0.0%
1991	- USD	0.0%
1990	- USD	0.0%
1989	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	2.5 Billion USD	-0.43%
2024 Q1	2.51 Billion USD	-0.42%
2024 Q3	2.46 Billion USD	-1.47%
2023 Q3	2.98 Billion USD	123.65%
2023 Q2	1.33 Billion USD	4.1%
2023 Q1	1.28 Billion USD	-4.72%
2023 FY	2.52 Billion USD	87.99%
2023 Q4	2.52 Billion USD	-15.26%
2022 Q2	1.29 Billion USD	6.48%
2022 FY	1.34 Billion USD	-0.53%
2022 Q4	1.34 Billion USD	-2.23%
2022 Q3	1.37 Billion USD	6.24%
2022 Q1	1.21 Billion USD	-10.07%
2021 FY	1.35 Billion USD	26.47%
2021 Q2	1.25 Billion USD	7.08%
2021 Q1	1.17 Billion USD	9.66%
2021 Q4	1.35 Billion USD	0.27%
2021 Q3	1.34 Billion USD	7.42%
2020 Q3	1.02 Billion USD	7.87%
2020 Q1	858.8 Million USD	6.79%
2020 FY	1.06 Billion USD	32.88%
2020 Q2	952.7 Million USD	10.93%
2020 Q4	1.06 Billion USD	3.98%
2019 Q4	804.2 Million USD	6.97%
2019 Q1	770.2 Million USD	-17.17%
2019 Q2	776.7 Million USD	0.84%
2019 Q3	751.8 Million USD	-3.21%
2019 FY	804.2 Million USD	-13.52%
2018 Q1	890.8 Million USD	-1.32%
2018 Q4	929.9 Million USD	1.45%
2018 Q3	916.6 Million USD	-1.62%
2018 FY	929.9 Million USD	3.01%
2018 Q2	931.7 Million USD	4.59%
2017 Q3	1 Billion USD	7.55%
2017 FY	902.7 Million USD	-9.87%
2017 Q1	921.6 Million USD	-7.99%
2017 Q4	902.7 Million USD	-10.38%
2017 Q2	936.5 Million USD	1.62%
2016 Q4	1 Billion USD	-0.8%
2016 Q1	964.6 Million USD	7.97%
2016 Q2	996.4 Million USD	3.3%
2016 Q3	1 Billion USD	1.33%
2016 FY	1 Billion USD	12.11%
2015 FY	893.4 Million USD	11.12%
2015 Q1	825.34 Million USD	2.65%
2015 Q2	865.73 Million USD	4.89%
2015 Q3	918.92 Million USD	6.14%
2015 Q4	893.4 Million USD	-2.78%
2014 Q4	804.02 Million USD	6.77%
2014 FY	804.02 Million USD	22.01%
2014 Q3	753.06 Million USD	5.19%
2014 Q2	715.93 Million USD	6.42%
2014 Q1	672.75 Million USD	2.09%
2013 Q2	570.39 Million USD	12.6%
2013 Q1	506.55 Million USD	13.23%
2013 FY	659 Million USD	47.31%
2013 Q4	659 Million USD	7.25%
2013 Q3	614.48 Million USD	7.73%
2012 Q4	447.37 Million USD	13.86%
2012 FY	447.37 Million USD	36.88%
2012 Q2	362.94 Million USD	7.5%
2012 Q3	392.9 Million USD	8.25%
2012 Q1	337.61 Million USD	3.3%
2011 FY	326.84 Million USD	13.07%
2011 Q3	310.93 Million USD	0.87%
2011 Q4	326.84 Million USD	5.12%
2011 Q2	308.25 Million USD	4.4%
2011 Q1	295.26 Million USD	2.14%
2010 Q1	280.03 Million USD	-4.73%
2010 FY	289.06 Million USD	-1.66%
2010 Q3	269.31 Million USD	0.54%
2010 Q4	289.06 Million USD	7.33%
2010 Q2	267.87 Million USD	-4.34%
2009 FY	293.95 Million USD	11.51%
2009 Q4	293.95 Million USD	5.48%
2009 Q3	278.68 Million USD	3.78%
2009 Q2	268.52 Million USD	0.17%
2009 Q1	268.07 Million USD	1.7%
2008 Q4	263.6 Million USD	5.5%
2008 FY	263.6 Million USD	12.66%
2008 Q3	249.85 Million USD	-2.03%
2008 Q2	255.02 Million USD	7.53%
2008 Q1	237.17 Million USD	1.36%
2007 Q4	233.98 Million USD	4.99%
2007 FY	233.98 Million USD	38.37%
2007 Q1	186.22 Million USD	10.12%
2007 Q2	207.89 Million USD	11.64%
2007 Q3	222.85 Million USD	7.2%
2006 Q3	155.11 Million USD	5.51%
2006 Q4	169.1 Million USD	9.01%
2006 Q1	191.02 Million USD	4.49%
2006 FY	169.1 Million USD	-7.5%
2006 Q2	147.02 Million USD	-23.03%
2005 Q2	243.53 Million USD	2.92%
2005 Q4	182.81 Million USD	-19.63%
2005 Q1	236.62 Million USD	-5.73%
2005 FY	182.81 Million USD	-27.17%
2005 Q3	227.46 Million USD	-6.6%
2004 Q3	246.36 Million USD	5.84%
2004 FY	251.01 Million USD	-49.43%
2004 Q1	311.39 Million USD	-37.26%
2004 Q2	232.76 Million USD	-25.25%
2004 Q4	251.01 Million USD	1.89%
2003 FY	496.34 Million USD	420.4%
2003 Q2	83.5 Million USD	-10.89%
2003 Q1	93.7 Million USD	-1.75%
2003 Q3	93.98 Million USD	12.55%
2003 Q4	496.34 Million USD	428.13%
2002 FY	95.37 Million USD	116.24%
2002 Q4	95.37 Million USD	302.3%
2002 Q3	23.7 Million USD	71.7%
2002 Q2	13.8 Million USD	88.15%
2002 Q1	7.33 Million USD	-83.36%
2001 FY	44.1 Million USD	10.14%
2001 Q4	44.1 Million USD	19077.39%
2001 Q3	230 Thousand USD	-99.48%
2001 Q2	43.99 Million USD	-9.24%
2001 Q1	48.47 Million USD	21.05%
2000 FY	40.04 Million USD	-20.8%
2000 Q4	40.04 Million USD	-28.84%
2000 Q3	56.27 Million USD	-5.78%
2000 Q2	59.73 Million USD	2.85%
2000 Q1	58.07 Million USD	14.85%
1999 Q1	- USD	-100.0%
1999 FY	50.56 Million USD	90.21%
1999 Q4	50.56 Million USD	0.0%
1999 Q3	- USD	0.0%
1999 Q2	- USD	0.0%
1998 Q1	- USD	-100.0%
1998 Q2	- USD	0.0%
1998 Q3	- USD	0.0%
1998 Q4	26.58 Million USD	0.0%
1998 FY	26.58 Million USD	-28.54%
1997 Q1	- USD	-100.0%
1997 FY	37.2 Million USD	-22.31%
1997 Q2	- USD	0.0%
1997 Q3	- USD	0.0%
1997 Q4	37.2 Million USD	0.0%
1996 Q2	16.6 Million USD	39.5%
1996 FY	47.88 Million USD	0.0%
1996 Q1	11.9 Million USD	0.0%
1996 Q3	16.8 Million USD	1.2%
1996 Q4	47.88 Million USD	185.05%
1995 Q4	- USD	0.0%
1995 Q3	- USD	0.0%
1995 Q1	- USD	0.0%
1995 FY	- USD	0.0%
1995 Q2	- USD	0.0%
1994 Q3	- USD	0.0%
1994 Q1	- USD	0.0%
1994 Q2	- USD	0.0%
1994 Q4	- USD	0.0%
1994 FY	- USD	0.0%
1993 Q3	- USD	0.0%
1993 Q2	- USD	0.0%
1993 Q1	- USD	0.0%
1993 FY	- USD	0.0%
1993 Q4	- USD	0.0%
1992 Q3	- USD	0.0%
1992 Q1	- USD	0.0%
1992 Q4	- USD	0.0%
1992 FY	- USD	0.0%
1992 Q2	- USD	0.0%
1991 Q3	- USD	0.0%
1991 Q4	- USD	0.0%
1991 FY	- USD	0.0%
1991 Q1	- USD	0.0%
1991 Q2	- USD	0.0%
1990 FY	- USD	0.0%
1990 Q3	- USD	0.0%
1990 Q4	- USD	0.0%
1990 Q2	- USD	0.0%
1990 Q1	- USD	0.0%
1989 FY	- USD	0.0%
1989 Q4	- USD	0.0%
1989 Q3	- USD	0.0%

Peer Inventory Comparison of Biogen Inc.

Name	Inventory	Inventory Difference
Amgen Inc.	9.51 Billion USD	73.446%
AstraZeneca PLC	5.42 Billion USD	53.403%
Gilead Sciences, Inc.	3.36 Billion USD	24.914%
MIRA Pharmaceuticals, Inc.	-11.86 Thousand USD	21306793.644%
Scilex Holding Company	4.21 Million USD	-59876.27%
Scilex Holding Company	4.21 Million USD	-59876.27%

Global Stocks Search

Biogen Inc. (BIIB)

Inventory Summary of Biogen Inc.

Annual Inventory Chart of Biogen Inc. (2023 - 1989)

Historical Annual Inventory of Biogen Inc. (2023 - 1989)

Peer Inventory Comparison of Biogen Inc.